Clinical value of soluble tumor necrosis factor-alpha receptors in patients with systemic lupus erythematosus

Clinical value of soluble tumor necrosis factor-alpha receptors in patients with systemic lupus erythematosus

The study was undertaken to examine the clinical value of serum levels of soluble receptors of tumor necrosis factor-alpha with a molecular mass of 55 kDa (rTNF-alpha-55R) in patients with systemic lupus erythematosus (SLE). The serum level of rTNF-alpha-55R was measured by enzyme immunoassay (a &qu...

Full description

Saved in:
Bibliographic Details
Published in:Klinicheskaia meditsina Vol. 82; no. 10; p. 51
Main Authors: Krichevskaia, O A, Kliukvina, N G, Aleksandrova, E N, Samsonov, M Iu, Nasonov, E L
Format: Journal Article
Language:Russian
Published: Russia (Federation) 2004
Subjects:
Adolescent
Adult
Biomarkers
Disease Progression
Female
Humans
Immunoenzyme Techniques
Lupus Erythematosus, Systemic - blood
Lupus Erythematosus, Systemic - diagnosis
Male
Middle Aged
Molecular Weight
Prognosis
Receptors, Tumor Necrosis Factor - blood
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The study was undertaken to examine the clinical value of serum levels of soluble receptors of tumor necrosis factor-alpha with a molecular mass of 55 kDa (rTNF-alpha-55R) in patients with systemic lupus erythematosus (SLE). The serum level of rTNF-alpha-55R was measured by enzyme immunoassay (a "Quantikine" set, R&D System, USA) in 73 patients with SLE and 22 donors. In the patients, the mean level of rTNF-alpha-55R was significantly higher than that in donors. Higher serum levels of rTNF-alpha-55R were noted in 43.8% of the patients with SLE. There was a correlation between the level of rTNF-alpha-55R and the progression of SLE (p < 0.05), the exacerbation (p < 0.05), and the clinical manifestations of the disease (cardiac valvular apparatus damage, active lupus nephritis). rTNF-alpha-55R are a marker of the progression and exacerbation of SLE and reflects that there is a prognostically poor factor, i.e. the involvement of the kidneys in a pathological process.
ISSN:0023-2149